Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01122238 · ClinicalTrials.gov registry record · Phase 4
Identifying Treatments to Motivate Smokers to Quit
A Phase 4 study of Smoking Cessation and Smoking, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 4
- Development phase
- 517
- Enrollment target
- 1
- Study location
NCT01122238: Completed Phase 4 study of Smoking Cessation and Smoking, sponsored by University of Wisconsin, Madison.
NCT01122238 is a Phase 4 study of Smoking Cessation and Smoking that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 517 participants, above the 472-participant average among 188 other Smoking Cessation trials with a reported enrollment target (10% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01122238, a Phase 4 study of Smoking Cessation and Smoking, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 517 participants
- Enrollment target
- 1
- Study location
Study Summary
At any given point in time, most smokers are not interested in making a serious quit attempt. Data suggest that 30% of smokers have no plans to quit, 30% plan to quit at some future date, 30% plan to quit in the next 6 months, and about 10% plan to quit in the next month. While \~40% of smokers make a quit attempt each year, only about 4-6% of those achieve long-term success. This means that of the more than 60 million Americans who smoke, only 1 million are able to quit each year. If we could double the number of quit attempts and maintain comparable success rates, we could double the number of individuals who will benefit from living smoke free lives. These observations underscore the need to develop interventions that increase smokers' motivation or willingness to make quit attempts, and that also increase the rate of success among those who attempt to quit. The overall goal of this proposed experiment is to identify effective interventions aimed at increasing motivation for smoking cessation, increasing quit attempts, and increasing rates of cessation success. Interventions that will be tested include: use of nicotine gum, use of nicotine patches, motivational interviewing, and smoking reduction counseling. At minimum, all participants will complete surveys about their smoking behavior that might increase their motivation to eventually quitting smoking.
Primary Outcome
Percent Change in Cigarettes Smoked Per Day (CPD) is computed as the percent change in self-reported cigarettes smoked per day at the assessment endpoint relative to baseline CPD; this outcome will be analyzed in a linear regression analysis model. Note: This Percent change in Cigarettes Smoked Per Day (CPD) primary outcome replaces "average number of cigarettes per day in the past week" (now designated as a secondary outcome) because the percent change metric allows better comparison with prio
Conditions Studied
Interventions
- OTHER No Intervention
- BEHAVIORAL Motivational Interviewing
- DRUG Nicotine Patch
- DRUG Nicotine Gum
- BEHAVIORAL Smoking Reduction
Study Locations (1)
Wisconsin
- University of Wisconsin Center for Tobacco Research and Intervention, School of Medicine and Public Health - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 517 participants |
| Start Date | 2010-06 |
| Est. Completion | 2014-05 |
| Phase | Phase 4 |
What the finished NCT01122238 record still lists
NCT01122238 is an interventional study that assigns participants to a tested intervention. The registered 517 participants enrollment target is mid-sized for trials with a published cap, above the 472-participant average among 188 other Smoking Cessation trials with a reported enrollment target (10% higher).
The record links to 4 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 5 interventions - of which No Intervention is the first listed.
NCT01122238 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT01122238 about?
NCT01122238 is a clinical study titled "Identifying Treatments to Motivate Smokers to Quit". At any given point in time, most smokers are not interested in making a serious quit attempt. Data suggest that 30% of smokers have no plans to quit, 30% plan to quit at some future date, 30% plan to quit in the next 6 months, and about 10% plan to quit in the next month. While \~40% of smokers make...
What is the current status of trial NCT01122238?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 517 participants. The study started on 2010-06. Estimated completion is 2014-05.
What conditions does trial NCT01122238 study?
This clinical trial studies the following conditions: Smoking Cessation, Smoking, Nicotine Dependence, Motivation.
What interventions are being tested in trial NCT01122238?
The interventions under investigation include: No Intervention (OTHER), Motivational Interviewing (BEHAVIORAL), Nicotine Patch (DRUG), Nicotine Gum (DRUG), Smoking Reduction (BEHAVIORAL).
Who is sponsoring clinical trial NCT01122238?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01122238 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01122238's enrollment target sits among peer trials
517 51st of 188 higher than 138 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
RECRUITING · Phase 4
-
The Options 2 Study
RECRUITING · Phase 4
-
Smoking Cessation Program in the Construction Sector
RECRUITING · Phase 4
-
The Avenues Study: Dual Use Cessation
RECRUITING · Phase 4
-
Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care
RECRUITING · Phase 4
-
Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites
ACTIVE NOT RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05676450 · 517 participants · NA
Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas
- NCT04524871 · 518 participants · Phase 1
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)
- NCT07112196 · 518 participants · Phase 2
Visugromab in Cachexia International Trial
- NCT05933083 · 516 participants · NA
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia